Centre raises alarm on adverse reaction caused by widely used life-saving beta blocker drugs

Concerned over the widely used life-saving beta blocker drugs causing adverse drug reactions, the government’s Indian Pharmacopoeia Commission (IPC) has issued an alert about the same.

An adverse drug reaction (ADR) is a harmful, unintended result caused by taking medication. ADRs may occur following a single dose or prolonged administration of a drug or may result from the combination of two or more drugs.

This is important as doctors widely prescribe the beta blocker medication to manage abnormal heart rhythms, prevent heart attack and migraine.

During a recently conducted analysis of Adverse Drug Reactions (ADRs), the commission found that the use of drugs such as metoprolol, propranolol, and atenolol can cause “Hypokalaemia”—a life-threatening condition due to potassium deficiency in the body.

Medically, the drugs metoprolol, propranolol and atenolol are used to treat hypertension in adults, functional heart disorders, migraine prophylaxis, cardiac arrhythmias, management of angina; essential and renal hypertension and other heart disorders.

“The analysis of adverse drug reactions from Pharmacovigilance Programme of India (PvPI) database revealed that beta blocker drugs (Metoprolol, Propranolol, and Atenolol) to cause adverse drug reaction,” stated IPC’s drug safety alert reviewed by Mint.

India’s beta-blocker market is currently valued at $11.06 billion and is expected to touch $15.08 billion by 2030.

India is one of the largest producers of quality medicines and has a robust pharmacovigilance system to monitor the safety profile of marketed pharmaceutical products.

“Healthcare professionals, patients or consumers are advised to closely monitor the possibility of the above ADR associated with the use of above suspected drug. If such a reaction is encountered, please report to the IPC,” it said.

IPC monitors adverse drug reactions among Indian population and helps the Central Drugs Standard Control Organization (CDSCO) take regulatory decisions for the safe use of medicines.

From March till December, around 13 different drugs were found to be showing adverse drug reaction as declared by IPC.

Related Posts

Rajasthan Bans Common Anaesthesia Injection Batch Used In Caesarean Deliveries And Surgeries: What Patients Need To Know

Rajasthan Drug Controller Ajay Phatak said that the Bupivacaine Hydrochloride in Dextrose, manufactured by Themis Medicare Limited, Batch No. BKP02601 has been restricted for sale and use. The Rajasthan Drug…

Raj orders statewide inspection of blood centres for compliance with safety norms

Jaipur: Rajasthan’s Health Department, Wednesday, ordered intensified inspections of all govt, non-govt and private blood centres after repeated violations of safety and operational norms. Recent inspections led to suspension of 69 licences…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Aster Quality Care all set to make Advanced Healthcare Ubiquitous in India

Aster Quality Care all set to make Advanced Healthcare Ubiquitous in India

Rajasthan Bans Common Anaesthesia Injection Batch Used In Caesarean Deliveries And Surgeries: What Patients Need To Know

Rajasthan Bans Common Anaesthesia Injection Batch Used In Caesarean Deliveries And Surgeries: What Patients Need To Know

Raj orders statewide inspection of blood centres for compliance with safety norms

Raj orders statewide inspection of blood centres for compliance with safety norms

mRNA Vaccines Proven Safe And Highly Effective Against Severe Infectious Diseases, Finds Lancet Review

mRNA Vaccines Proven Safe And Highly Effective Against Severe Infectious Diseases, Finds Lancet Review

Telangana bets big on drug discovery hub

Telangana bets big on drug discovery hub

Mankind Pharma joins hands with Denovo Sciences for AI-powered drug discovery

Mankind Pharma joins hands with Denovo Sciences for AI-powered drug discovery